Erling Bjerregaard Pedersen

Author PubWeight™ 20.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial. Anesthesiology 2014 3.24
2 Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur J Heart Fail 2005 1.64
3 The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial. Anesth Analg 2015 1.08
4 Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007 1.06
5 Blood pressure control during telemonitoring of home blood pressure. A randomized controlled trial during 6 months. Blood Press 2008 0.99
6 Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. Am J Physiol Renal Physiol 2008 0.99
7 Effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans. Am J Physiol Renal Physiol 2011 0.89
8 Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man. Clin Exp Hypertens 2012 0.86
9 Catheter-based renal denervation for treatment of resistant hypertension. Dan Med J 2012 0.84
10 Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension. BMC Nephrol 2012 0.84
11 Effect of amiloride and spironolactone on renal tubular function, ambulatory blood pressure, and pulse wave velocity in healthy participants in a double-blinded, randomized, placebo-controlled, crossover trial. Clin Exp Hypertens 2012 0.83
12 Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Nephrol Dial Transplant 2007 0.82
13 Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion. Am J Physiol Renal Physiol 2012 0.82
14 Effects of atorvastatin on systemic and renal nitric oxide in healthy man. Clin Exp Hypertens 2012 0.81
15 Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans. Kidney Int 2005 0.80
16 Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects. BMC Nephrol 2014 0.79
17 Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial. Blood Press 2010 0.79
18 [Nephrogen systemic fibrosis is reported in a dialysis patient after MR-angiography with a contrast medium]. Ugeskr Laeger 2008 0.77
19 Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease. Br J Clin Pharmacol 2014 0.76
20 Associations of objectively measured physical activity and abdominal fat distribution. Med Sci Sports Exerc 2015 0.76
21 Effects of dihydralazine on renal water and aquaporin-2 excretion in humans. Scand J Clin Lab Invest 2009 0.75
22 [Lithium can be given to patients on haemodialysis treatment]. Ugeskr Laeger 2015 0.75
23 [Acute oliguric renal failure and haemolytic anaemia following infectious mononucleosis]. Ugeskr Laeger 2015 0.75
24 [Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation]. Ugeskr Laeger 2011 0.75
25 Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites. Scand J Gastroenterol 2015 0.75
26 [High doses of aldosterone antagonist is a condition of sufficient blood pressure control in bilateral adrenal hyperplasia]. Ugeskr Laeger 2015 0.75
27 Transjugular intrahepatic portosystemic shunt: impact on systemic haemodynamics and renal and cardiac function in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol 2017 0.75
28 [Genetics and hypertension]. Ugeskr Laeger 2009 0.75
29 Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor. Scand J Clin Lab Invest 2007 0.75
30 [Improved prognosis in light chain nephropathy due to multiple myeloma]. Ugeskr Laeger 2012 0.75